Company / Tangible Book Value per Share
Arbutus Biopharma Corp Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.40
FY2025
5-year range
$0.40 / $1.89
FY2021-FY2025
Trend
-29.7%
vs FY2024
Sector context
#177 of 209
Health Care
What the data says
Arbutus Biopharma Corp's tangible book value per share of $0.40 is lower than 85% of companies in the Health Care sector (FY2025). Tangible Book Value per Share has declined for 4 consecutive years, from $1.89 in FY2021 to $0.40 in FY2025.
Based on SEC 10-K filings.
0.40 in FY2025 with a 5-year CAGR of -18.5%.
Declined from $0.67 to $0.40 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -24.7%
- 5-Year CAGR
- -18.5%
- 10-Year CAGR
- -
Sector benchmark
-99.6% below sector average
Key checks
Key Insights
- Arbutus Biopharma Corp's tangible book value per share has declined for 4 consecutive years.
- In FY2025, tangible book value per share decreased 29.7% year-over-year.
- Ranks #177 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.40 | -29.7% |
| FY2024 | $0.57 | -14.9% |
| FY2023 | $0.67 | -28.7% |
| FY2022 | $0.94 | -50.0% |
| FY2021 | $1.89 | +68.3% |
| FY2020 | $1.12 | -68.9% |
| FY2019 | $3.61 | +24.1% |
| FY2018 | $2.91 | +1.2% |
| FY2017 | $2.87 | -11.8% |
| FY2016 | $3.26 | -53.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026